Skandinaviska Enskilda Banken Ab (Publ) Vertex Pharmaceuticals Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $24.3 Billion
  • Q3 2025

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 154,248 shares of VRTX stock, worth $66.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
154,248
Previous 176,604 12.66%
Holding current value
$66.9 Million
Previous $78.6 Million 23.17%
% of portfolio
0.25%
Previous 0.35%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$366.54 - $479.53 $8.19 Million - $10.7 Million
-22,356 Reduced 12.66%
154,248 $60.4 Million
Q2 2025

Aug 13, 2025
SELL
$421.16 - $509.5 $4.16 Million - $5.03 Million
-9,867 Reduced 5.29%
176,604 $78.6 Million
Q1 2025

May 07, 2025
BUY
$402.49 - $513.76 $6.21 Million - $7.93 Million
15,437 Added 9.03%
186,471 $90.4 Million
Q4 2024

Feb 10, 2025
SELL
$396.64 - $516.74 $5.65 Million - $7.36 Million
-14,251 Reduced 7.69%
171,034 $68.9 Million
Q3 2024

Nov 07, 2024
SELL
$460.0 - $505.78 $15.4 Million - $17 Million
-33,548 Reduced 15.33%
185,285 $86.2 Million
Q2 2024

Aug 13, 2024
SELL
$392.81 - $485.53 $18.1 Million - $22.4 Million
-46,090 Reduced 17.4%
218,833 $103 Million
Q1 2024

May 13, 2024
BUY
$407.69 - $446.08 $8.64 Million - $9.45 Million
21,185 Added 8.69%
264,923 $111 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $28.4 Million - $34 Million
-82,892 Reduced 25.38%
243,738 $99.2 Million
Q3 2023

Nov 09, 2023
SELL
$338.18 - $362.46 $17 Million - $18.2 Million
-50,316 Reduced 13.35%
326,630 $114 Million
Q2 2023

Aug 07, 2023
SELL
$314.42 - $351.91 $21.1 Million - $23.6 Million
-67,057 Reduced 15.1%
376,946 $133 Million
Q1 2023

May 11, 2023
BUY
$283.23 - $323.1 $10.6 Million - $12.1 Million
37,469 Added 9.22%
444,003 $140 Million
Q4 2022

Feb 08, 2023
BUY
$285.76 - $321.48 $15.7 Million - $17.6 Million
54,823 Added 15.59%
406,534 $117 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $27 Million - $30.1 Million
98,458 Added 38.88%
351,711 $102 Million
Q2 2022

Aug 10, 2022
BUY
$234.96 - $292.55 $4.99 Million - $6.21 Million
21,221 Added 9.15%
253,253 $71.4 Million
Q1 2022

May 11, 2022
SELL
$221.42 - $260.97 $12.4 Million - $14.6 Million
-55,892 Reduced 19.41%
232,032 $60.6 Million
Q4 2021

Feb 10, 2022
SELL
$177.01 - $223.45 $1.8 Million - $2.27 Million
-10,161 Reduced 3.41%
287,924 $64 Million
Q3 2021

Nov 10, 2021
SELL
$181.39 - $202.99 $1.54 Million - $1.72 Million
-8,478 Reduced 2.77%
298,085 $54.1 Million
Q2 2021

Aug 10, 2021
SELL
$187.49 - $221.1 $7.25 Million - $8.54 Million
-38,644 Reduced 11.19%
306,563 $61.8 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $16.3 Million - $19 Million
78,854 Added 29.61%
345,207 $74.2 Million
Q4 2020

Feb 11, 2021
SELL
$207.01 - $276.09 $481,505 - $642,185
-2,326 Reduced 0.87%
266,353 $63 Million
Q3 2020

Nov 12, 2020
SELL
$255.65 - $303.1 $2.51 Million - $2.97 Million
-9,801 Reduced 3.52%
268,679 $73.1 Million
Q2 2020

Aug 13, 2020
BUY
$225.48 - $295.8 $23.8 Million - $31.2 Million
105,390 Added 60.89%
278,480 $80.8 Million
Q1 2020

May 13, 2020
BUY
$199.77 - $247.81 $11.5 Million - $14.3 Million
57,812 Added 50.15%
173,090 $41.2 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $592,820 - $796,223
3,556 Added 3.18%
115,278 $25.2 Million
Q3 2019

Nov 08, 2019
BUY
$166.23 - $187.09 $2.24 Million - $2.52 Million
13,493 Added 13.74%
111,722 $18.9 Million
Q2 2019

Aug 09, 2019
SELL
$164.61 - $190.37 $1.34 Million - $1.55 Million
-8,136 Reduced 7.65%
98,229 $18 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $3.9 Million - $4.64 Million
23,809 Added 28.84%
106,365 $19.6 Million
Q4 2018

Feb 12, 2019
BUY
$151.91 - $192.21 $405,751 - $513,392
2,671 Added 3.34%
82,556 $13.7 Million
Q3 2018

Nov 05, 2018
BUY
$167.73 - $192.74 $201,276 - $231,288
1,200 Added 1.53%
79,885 $15.4 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $1.53 Million - $1.78 Million
10,485 Added 15.37%
78,685 $13.4 Million
Q1 2018

Apr 30, 2018
SELL
$151.6 - $177.13 $1.57 Million - $1.83 Million
-10,331 Reduced 13.16%
68,200 $11.1 Million
Q4 2017

Feb 12, 2018
SELL
$137.28 - $155.55 $2.14 Million - $2.43 Million
-15,600 Reduced 16.57%
78,531 $11.8 Million
Q3 2017

Nov 13, 2017
SELL
$148.13 - $162.24 $1.96 Million - $2.14 Million
-13,200 Reduced 12.3%
94,131 $14.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
107,331
107,331 $0

Others Institutions Holding VRTX

# of Institutions
1,791
Shares Held
231M
Call Options Held
1.84M
Put Options Held
1.21M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $111B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email